BMN 701

· BioMarin Pharmaceutical

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for BMN 701, covering 2018-05-22 to 2018-06-14. Get the full timeline:

Most recent: Clinical Trial Update: BMN 701 Phase 3 in rhGAA Exposed Subjects With Late Onset Pompe Disease (INSPIRE Study) [Phase 3]